Get App
Download App Scanner
Scan to Download
Advertisement

Shilpa Medicare Announces 1:1 Bonus Issue After Q1 Profit Triples — Check Record Date

Shilpa Medicare Announces 1:1 Bonus Issue After Q1 Profit Triples — Check Record Date
This is the first bonus shares issue of Shilpa Medicare in over 12 years, with the previous instance of the company having done so being in 2013. (Photo: Envato)
  • Shilpa Medicare announced a 1:1 bonus share issue, first in over 12 years
  • Net profit tripled to Rs 47 crore in June quarter from Rs 14 crore year ago
  • Board approved bonus shares with record date set for 26 September 2025
Did our AI summary help?
Let us know.

Shilpa Medicare Ltd. announced the issue of bonus shares through an exchange filing on Wednesday, with shareholders owning each equity share of face value Rs 1 to receive a bonus share of the same face value.

This is the first bonus shares issue the company has made in over 12 years, with previous instance of the company having done so being in 2013.

The niche active pharmaceutical ingredient manufacturer saw its net profit triple to Rs 47 crore from Rs 14 crore in the quarter ended June.

The decision was made during a meeting of the company's board of directors held on Wednesday.

The record date for determining the eligibility of shareholders to receive the bonus shares will be Sept. 26, 2025. The bonus shares will be dispatched within two months of their declaration.

The paid-up capital as on date is Rs 9.77 crore and and after bonus issue, it would be increased to Rs 19.55 crore , as per a press release.

Shilpa Medicare Q1FY26 Highlights (Consolidated, YoY)

  • Revenue up 9.9% to Rs 321 crore versus Rs 293 crore

  • Net profit at Rs 46.9 crore versus Rs 14.1 crore

  • Ebitda up 24.6% to Rs 91.6 crore versus Rs 73.5 crore

  • Margin at 28.5% versus 25.1%

Shares of Shilpa Medicare closed 5% higher at Rs 913.70 apiece on the NSE, compared to a 0.54% rise in the benchmark Nifty 50. The stock has risen 36.1% in the last 12 months and 12.04% on a year-to-date basis.

Out of three analysts tracking the company, two have a 'buy' rating on the stock, and one recommends 'hold', according to Bloomberg data. The average of 12-month analysts' price target implies a potential upside of 6.5%.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search